In this sense, the combination of TNF-α and secondary mitochondria-derived activator of caspases (SMAC) mimetics has been reported to induce immunogenic cell death in fibrosarcoma, melanoma, liposarcoma, synovial sarcoma and patient-derived cutaneous squamous cell carcinoma. Here, TNF is linked to melanoma.